March 19, 2015
The Central Social Insurance Medical Council (Chuikyo) approved the addition of ViiV Healthcare K.K.’s HIV treatment Triumeq combination tablets (dolutegravir + abacavir + lamivudine) to the NHI price list at a general meeting on March 18. Listing is scheduled for...read more